Clinical Trial Update: Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on NRD135S.E1 for diabetic peripheral neuropathy with neuropathic pain. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• NRD135S.E1

Snippet

Sponsor: Novaremed Ltd. | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED